Genomic analysis identified kinase signaling alterations in 91% of patients with Ph-like ALL, and they were divided into distinct subgroups. These included JAK-STAT mutations, ABL class fusion, RAS pathway mutations, other uncommon mutations, and no kinase alterations [10]. Here, ABL1 is linked to acute lymphoblastic leukemia.